CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase Ib Prospective Clinical Study Evaluating the Safety and Efficacy of Propranolol Combined With Tislelizumab Plus Gemcitabine/Cisplatin as Neoadjuvant Therapy for cT1-4aN1-3M0 Bladder Urothelial Carcinoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT07353294
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:29:05.403117+00:00
Published At: 2026-04-22T00:00:00+00:00
Record Updated At: 2026-04-22
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Bladder Urothelial Carcinoma", "Lymph Node Metastasis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-04-22"
protocolSection.identificationModule.nctId: "NCT07353294"
protocolSection.identificationModule.officialTitle: "A Phase Ib Prospective Clinical Study Evaluating the Safety and Efficacy of Propranolol Combined With Tislelizumab Plus Gemcitabine/Cisplatin as Neoadjuvant Therapy for cT1-4aN1-3M0 Bladder Urothelial Carcinoma"
protocolSection.statusModule.overallStatus: "ENROLLING_BY_INVITATION"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.